Articles by Disease (Glioma)

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

Journal: Current Cancer Drug Targets
Volume: 11
Page: 254-284
Author(s): G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar

Targeting Proteasomes with Naturally Occurring Compounds in Cancer Treatment

Journal: Current Cancer Drug Targets
Volume: 11
Page: 307-324
Author(s): V. Cecarini, M. Cuccioloni, M. Mozzicafreddo, L. Bonfili, M. Angeletti and A. M. Eleuteri

Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome

Journal: Current Cancer Drug Targets
Volume: 11
Page: 332-337
Author(s): B. Cvek

Autophagy: Molecular Mechanisms and their Implications for Anticancer Therapies

Journal: Current Cancer Drug Targets
Volume: 11
Page: 357-379
Author(s): S. Meschini, M. Condello, P. Lista and G. Arancia

Peptidyl Prolyl Isomerase, Pin1 is a Potential Target for Enhancing the Therapeutic Efficacy of Etoposide

Journal: Current Cancer Drug Targets
Volume: 11
Page: 380-392
Author(s): R. Mathur, S. Chandna, P. N. Kapoor and B. S. Dwarakanath

Decorin Biology, Expression, Function and Therapy in the Cornea

Journal: Current Molecular Medicine
Volume: 11
Page: 110-128
Author(s): R. R. Mohan, J. C.K. Tovey, R. Gupta, A. Sharma and A. Tandon

Glycans in Magnetic Resonance Imaging: Determinants of Relaxivity to Smart Agents, and Potential Applications in Biomedicine

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1002-1018
Author(s): Laura Cipolla, Maria Gregori and Po-Wah So